Link Pharma Chem Ltd.
Snapshot View

View in App

Prices View details >>

36.80 -2.05 ▼-5.3%

17 August 2022, 09:32:00 AM
Volume: 10,271

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.linkpharmachem.co.in
Market Cap 17.25 Cr.
Enterprise Value(EV) 22.76 Cr. 2022-03
Financial Indicators
Earnings per share (EPS) 4.24 Trailing Twelve Months Ending 2022-03
Price-Earning Ratio (PE) 9.17 Trailing Twelve Months Ending 2022-03
Industry PE 32.22 Trailing Twelve Months Ending 2022-03
Book Value / Share 32.60 Trailing Twelve Months Ending 2022-03
Price to Book Value 1.19 Calculated using Price: 38.85
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 0.44 Cr. 4,440,568 Shares
FaceValue 10
Company Profile
Link Pharma Chem, incorporated on December 28, 1984 is a manufacturer of thionyl chloride.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
-5.28%
1 Week
-18.04%
1 Month
-11.33%
3 Month
-18.49%
6 Month
-18.40%
1 Year
+9.85%
2 Year
+84.00%
5 Year
+207.44%
10 Year
+514.36%

Ratios View Details >>

9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 4.97 -23.07 6.83 2.58 12.34 6.53 8.71 9.04 13.92
Return on Capital Employed (%) 9.32 -8.74 9.83 9.26 15.38 10.31 12.87 13.58 16.57
Return on Assets (%) 2.01 -8.35 2.70 1.31 6.61 3.74 5.14 4.82 6.84

Balance Sheet View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Shh. Funds 10 11 8 9 9 10 10 11 13 14
Non Curr. Liab. 5 6 8 1 2 3 3 4 4 4
Curr. Liab. 9 10 9 7 7 4 5 3 9 11
Minority Int.
Equity & Liab. 25 26 26 18 17 17 18 19 26 29
Non Curr. Assets 16 17 18 10 10 11 11 10 11 15
Curr. Assets 9 10 8 7 7 7 7 9 15 14
Misc. Exp. not W/O
Total Assets 25 26 26 18 17 17 18 19 26 29

Profit Loss View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Net Sales 16 24 18 12 16 24 25 25 35 54
Other Income 0 0 0 3 0 0 0 0 0 1
Total Income 17 24 18 15 16 24 25 26 35 54
Total Expenditure -14 -21 -18 -13 -14 -21 -22 -23 -32 -50
PBIDT 2 3 -1 3 2 3 2 3 3 4
Interest -1 -1 -1 -1 -1 -1 0 0 0 0
Depreciation -1 -1 -1 -1 -1 -1 -1 -1 -1 -1
Taxation 0 0 1 0 0 0 0 0 -1 -1
Exceptional Items
PAT 0 1 -2 1 0 1 1 1 1 2
Adjusted EPS 1 1 -5 1 1 3 1 2 2 4

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. -1 1 5 -4 2 4 1 3 5 -1
Cash Fr. Inv. -1 -1 -3 9 -1 -1 -1 -2 -2 -5
Cash Fr. Finan. 2 0 -1 -6 -1 -3 0 1 0 2
Net Change 0 0 1 -1 0 0 2 2 -4
Cash & Cash Eqvt 0 0 1 0 0 0 0 2 4 0

Shareholding Pattern View Details >>

9 Qtrs 2020-06 (%) 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%)
Promoter 51.49 51.49 51.49 51.49 51.49 51.49 51.49 51.49 51.49
Public 48.50 48.51 48.51 48.51 48.51 48.51 48.51 48.51 48.51
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Sat, 13 Aug 2022
Unaudited Financial Results For The Quarter Ended On June 30 2022.
Pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we are enclosing herewith Unaudited Financial Results for the quarter ended on June 30 2022 along with Limited Review Report on Financial Results of the Company for the quarter ended on June 30 2022.
Fri, 05 Aug 2022
Shareholder Meeting / Postal Ballot-Outcome of AGM
In compliance with Regulation 30 read with Part A of Schedule III of the SESI (Listing Obligations and Disclosure Requirements) Regulations 2015 please find enclosed the summary of the proceedings of 37th Annual General Meeting of the Company held on Friday 05th August 2022 at 11:00 a.m. through Video Conferencing (VC) / Other Audio Visual Means (OAVM).
Fri, 05 Aug 2022
Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations 2015)
Link Pharma Chem Ltd has informed BSE regarding the details of Voting results of AGM under Regulation 44(3) of SEBI (LODR) Regulations 2015. Kindly Click here

Technical Scans View Details >>

Tue, 16 Aug 2022
Higher Delivery Quantity Higher Delivery Quantity
Higher Trade Quantity Higher Trade Quantity
Higher Trade and Delivery Quantity Higher Trade and Delivery Quantity
Close Crossing Last Week Low Close Crossing Last Week Low
Close Crossing Last Month Close from Above Close Crossing Last Month Close from Above

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 219,443.18 920.30 +0.6%
Divi's Laboratories Ltd. 99,072.87 3,760.55 +0.8%
Cipla Ltd. 83,487.41 1,037.35 +0.3%
Dr. Reddy's Laboratories Ltd. 71,536.21 4,312.90 +0.4%
Apollo Hospitals Enterprise Ltd. 62,537.70 4,330.10 -0.4%
Torrent Pharmaceuticals Ltd. 53,261.16 1,576.45 +0.2%
Piramal Enterprises Ltd. 45,983.34 1,935.10 +0.4%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 56.42 920.30 +0.6%
Divi's Laboratories Ltd. Consolidated 2022-06 31.92 3,760.55 +0.8%
Cipla Ltd. Consolidated 2022-06 33.44 1,037.35 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 23.91 4,312.90 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 70.76 4,330.10 -0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 66.33 1,576.45 +0.2%
Piramal Enterprises Ltd. Consolidated 2022-06 24.47 1,935.10 +0.4%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 4.38 920.30 +0.6%
Divi's Laboratories Ltd. Consolidated 2022-06 7.98 3,760.55 +0.8%
Cipla Ltd. Consolidated 2022-06 3.87 1,037.35 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 3.53 4,312.90 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 10.52 4,330.10 -0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 8.31 1,576.45 +0.2%
Piramal Enterprises Ltd. Consolidated 2022-06 1.28 1,935.10 +0.4%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.02 920.30 +0.6%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,760.55 +0.8%
Cipla Ltd. Consolidated 2022-03 0.04 1,037.35 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,312.90 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,330.10 -0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,576.45 +0.2%
Piramal Enterprises Ltd. Consolidated 2022-03 1.56 1,935.10 +0.4%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 920.30 +0.6%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,760.55 +0.8%
Cipla Ltd. Consolidated 2022-03 13.10 1,037.35 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,312.90 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,330.10 -0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,576.45 +0.2%
Piramal Enterprises Ltd. Consolidated 2022-03 3.87 1,935.10 +0.4%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 920.30 +0.6%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,760.55 +0.8%
Cipla Ltd. Consolidated 2022-03 13.10 1,037.35 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,312.90 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,330.10 -0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,576.45 +0.2%
Piramal Enterprises Ltd. Consolidated 2022-03 3.87 1,935.10 +0.4%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 920.30 +0.6%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,760.55 +0.8%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,037.35 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,312.90 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,330.10 -0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,576.45 +0.2%
Piramal Enterprises Ltd. Consolidated 2022-03 13,993.30 1,935.10 +0.4%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 920.30 +0.6%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,760.55 +0.8%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,037.35 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,312.90 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,330.10 -0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,576.45 +0.2%
Piramal Enterprises Ltd. Consolidated 2022-03 1,345.89 1,935.10 +0.4%

FAQ's On Link Pharma Chem Ltd.

Can I Buy Link Pharma Chem Shares now?
What is the Share Price of Link Pharma Chem?
What is the Relative Strength Index (RSI) Value of Link Pharma Chem?
What is the Market Capital (MCAP) of Link Pharma Chem?
What are the key metrics to analyse Link Pharma Chem?
What is the Price Performance of Link Pharma Chem?